Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image